Response by Goonewardena et al to Letter Regarding Article, "Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19"
- PMID: 39167673
- PMCID: PMC11382326
- DOI: 10.1161/ATVBAHA.124.321392
Response by Goonewardena et al to Letter Regarding Article, "Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19"
Conflict of interest statement
None.
Comment on
-
Letter by Brambilla et al Regarding Article, "Monocyte-Mediated Thrombosis Linked to Circulating Tissue-Factor and Immune Paralysis in COVID-19".Arterioscler Thromb Vasc Biol. 2024 Sep;44(9):e238-e239. doi: 10.1161/ATVBAHA.124.321299. Epub 2024 Aug 21. Arterioscler Thromb Vasc Biol. 2024. PMID: 39167674 No abstract available.
References
-
- Hottz ED, Martins-Gonçalves R, Palhinha L, Azevedo-Quintanilha IG, De Campos MM, Sacramento CQ, et al. Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19. Blood Advances 2022;6:5085–5099. doi: 10.1182/bloodadvances.2021006680. - DOI - PMC - PubMed
-
- Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, et al. Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. Journal of Clinical Investigation 2020;130:6151–6157. doi: 10.1172/JCI141374. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
